Special Issue "Antidiabetic Drugs"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (30 June 2010).
Special Issue Editor
Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
Interests: Oxygen radicals, antioxidants, heart failure, atherosclerosis, diabetes, flaxseed and its components, hypertension, hypercholesterolemia, acute coronary syndrome, advanced glycation end products, soluble receptor for advanced glycation end products, C-reactive protein, homocysteine, cytokines, phosphoenolpyruvate carboxykinase
Interests: Oxygen radicals, antioxidants, heart failure, atherosclerosis, diabetes, flaxseed and its components, hypertension, hypercholesterolemia, acute coronary syndrome, advanced glycation end products, soluble receptor for advanced glycation end products, C-reactive protein, homocysteine, cytokines, phosphoenolpyruvate carboxykinase
Keywords
- insulin
- exenatide
- pramlintide
- sulfonylurea
- meglitinides
- biguanides
- thiazolidinediones
- glucagon-like peptide (GLP) analogs and agonists
- DPP-4 inhibitors
- amylin analogues
- gastric inhibitory peptide (GIP) analogs
Related Special Issue
- Anti-Obesity Drugs in Pharmaceuticals (3 articles)